Twin Focus Capital Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Twin Focus Capital Partners's NVS Position: Q3 2023 in Review
Twin Focus Capital Partners sold out of Novartis (NVS) in Q3 2023, closing a stake of 2,110 shares — an estimated $213K sold.
Twin Focus Capital Partners first reported a position in NVS in Q3 2014 and held it in 16 quarters. The position peaked at $389K in Q4 2020. 1,222 funds tracked by Wall St. Rank hold NVS as of Q3 2023.
- Twin Focus Capital Partners reported no remaining Novartis position as of Q3 2023 after selling out during the quarter.
- Twin Focus Capital Partners sold 2,110 Novartis shares in Q3 2023, an estimated $213K.
- Twin Focus Capital Partners first reported a position in Novartis in Q3 2014 and held it in 16 quarters.
- Twin Focus Capital Partners's Novartis position peaked at $389K in Q4 2020.
- 1,222 funds tracked by Wall St. Rank held Novartis as of Q3 2023.
Based on Twin Focus Capital Partners's 13F filing for Q3 2023, filed 13 Nov 2023.